A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Healthy
Interventions
DRUG

Omeprazole

40 MG oral capsules daily

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus GG

Given as Culturelle Digestive Probiotic in the form of oral capsules daily

DRUG

Placebo

Oral capsules daily that look exactly like the study drug, but contains to active ingredient

Trial Locations (1)

85259

RECRUITING

Mayo Clinic Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05517928 - A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis | Biotech Hunter | Biotech Hunter